261 related articles for article (PubMed ID: 22362425)
1. Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow.
Frånberg O; Marcus MM; Svensson TH
Synapse; 2012 Jul; 66(7):650-60. PubMed ID: 22362425
[TBL] [Abstract][Full Text] [Related]
2. Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action.
López-Gil X; Artigas F; Adell A
Int J Neuropsychopharmacol; 2009 May; 12(4):487-99. PubMed ID: 18752722
[TBL] [Abstract][Full Text] [Related]
3. M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex.
Pehek EA; McFarlane HG; Maguschak K; Price B; Pluto CP
Brain Res; 2001 Jan; 888(1):51-59. PubMed ID: 11146051
[TBL] [Abstract][Full Text] [Related]
4. Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus.
Huang M; Li Z; Dai J; Shahid M; Wong EH; Meltzer HY
Neuropsychopharmacology; 2008 Nov; 33(12):2934-45. PubMed ID: 18418367
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.
Björkholm C; Frånberg O; Malmerfelt A; Marcus MM; Konradsson-Geuken Å; Schilström B; Jardemark K; Svensson TH
Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522408
[TBL] [Abstract][Full Text] [Related]
6. Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.
Martín-Ruiz R; Puig MV; Celada P; Shapiro DA; Roth BL; Mengod G; Artigas F
J Neurosci; 2001 Dec; 21(24):9856-66. PubMed ID: 11739593
[TBL] [Abstract][Full Text] [Related]
7. Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms.
Frånberg O; Marcus MM; Ivanov V; Schilström B; Shahid M; Svensson TH
Psychopharmacology (Berl); 2009 Jun; 204(2):251-64. PubMed ID: 19198810
[TBL] [Abstract][Full Text] [Related]
8. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex.
Amargós-Bosch M; Adell A; Artigas F
J Neurochem; 2007 Jul; 102(2):550-61. PubMed ID: 17394545
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological characterization of the effects of asenapine at 5-HT(1A), 5-HT(2A), alpha(2)-adrenergic and D(2) receptors in the rat brain.
Ghanbari R; El Mansari M; Shahid M; Blier P
Eur Neuropsychopharmacol; 2009 Mar; 19(3):177-87. PubMed ID: 19116183
[TBL] [Abstract][Full Text] [Related]
11. Asenapine alters the activity of monoaminergic systems following its subacute and long-term administration: an in vivo electrophysiological characterization.
Oosterhof CA; El Mansari M; Blier P
Eur Neuropsychopharmacol; 2015 Apr; 25(4):531-43. PubMed ID: 25656272
[TBL] [Abstract][Full Text] [Related]
12. DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release.
Ichikawa J; Dai J; Meltzer HY
Brain Res; 2001 Jul; 907(1-2):151-5. PubMed ID: 11430898
[TBL] [Abstract][Full Text] [Related]
13. In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs.
Bortolozzi A; Amargós-Bosch M; Adell A; Díaz-Mataix L; Serrats J; Pons S; Artigas F
Eur J Neurosci; 2003 Sep; 18(5):1235-46. PubMed ID: 12956722
[TBL] [Abstract][Full Text] [Related]
14. Unraveling monoamine receptors involved in the action of typical and atypical antipsychotics on glutamatergic and serotonergic transmission in prefrontal cortex.
López-Gil X; Artigas F; Adell A
Curr Pharm Des; 2010; 16(5):502-15. PubMed ID: 19909228
[TBL] [Abstract][Full Text] [Related]
15. SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Bonaccorso S; Meltzer HY; Li Z; Dai J; Alboszta AR; Ichikawa J
Neuropsychopharmacology; 2002 Sep; 27(3):430-41. PubMed ID: 12225700
[TBL] [Abstract][Full Text] [Related]
16. Reduced cortical serotonin 5-HT
Mora S; Merchán A; Vilchez O; Aznar S; Klein AB; Ultved L; Campa L; Suñol C; Flores P; Moreno M
Neuropharmacology; 2018 Dec; 143():10-19. PubMed ID: 30201211
[TBL] [Abstract][Full Text] [Related]
17. The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity.
Bortolozzi A; Díaz-Mataix L; Scorza MC; Celada P; Artigas F
J Neurochem; 2005 Dec; 95(6):1597-607. PubMed ID: 16277612
[TBL] [Abstract][Full Text] [Related]
18. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
Ichikawa J; Dai J; Meltzer HY
Brain Res; 2002 Jun; 939(1-2):34-42. PubMed ID: 12020849
[TBL] [Abstract][Full Text] [Related]
19. Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex.
Ohoyama K; Yamamura S; Hamaguchi T; Nakagawa M; Motomura E; Shiroyama T; Tanii H; Okada M
Eur J Pharmacol; 2011 Feb; 653(1-3):47-57. PubMed ID: 21147094
[TBL] [Abstract][Full Text] [Related]
20. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
Ichikawa J; Kuroki T; Dai J; Meltzer HY
Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
